Literature DB >> 10595352

Evaluation of antisense mechanisms of action.

C Ghosh1, D Stein, D Weller, P Iversen.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10595352     DOI： 10.1016/s0076-6879(00)13008-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  10 in total

1.  Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers.

Authors:  Richard M Kinney; Claire Y-H Huang; Becky C Rose; Andrew D Kroeker; Theo W Dreher; Patrick L Iversen; David A Stein
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Triplex formation by morpholino oligodeoxyribonucleotides in the HER-2/neu promoter requires the pyrimidine motif.

Authors:  J Basye; J O Trent; D Gao; S W Ebbinghaus
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

3.  Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.

Authors:  Qing Ge; Manoj Pastey; Darwyn Kobasa; Piliapan Puthavathana; Christopher Lupfer; Richard K Bestwick; Patrick L Iversen; Jianzhu Chen; David A Stein
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

4.  Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth.

Authors:  Benjamin W Neuman; David A Stein; Andrew D Kroeker; Amy D Paulino; Hong M Moulton; Patrick L Iversen; Michael J Buchmeier
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.

Authors:  Sven Enterlein; Kelly L Warfield; Dana L Swenson; David A Stein; Jeffery L Smith; C Scott Gamble; Andrew D Kroeker; Patrick L Iversen; Sina Bavari; Elke Mühlberger
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

6.  Development of novel bioanalytical methods to determine the effective concentrations of phosphorodiamidate morpholino oligomers in tissues and cells.

Authors:  Frederick J Schnell; Stacy L Crumley; Dan V Mourich; Patrick L Iversen
Journal:  Biores Open Access       Date:  2013-02

7.  Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Authors:  Kelly L Warfield; Dana L Swenson; Gene G Olinger; Donald K Nichols; William D Pratt; Robert Blouch; David A Stein; M Javad Aman; Patrick L Iversen; Sina Bavari
Journal:  PLoS Pathog       Date:  2006-01-13       Impact factor: 6.823

8.  Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers.

Authors:  M Alonso; D A Stein; E Thomann; H M Moulton; J C Leong; P Iversen; D V Mourich
Journal:  J Fish Dis       Date:  2005-07       Impact factor: 2.767

Review 9.  Nonviral delivery systems for antisense oligonucleotide therapeutics.

Authors:  Si Huang; Xin-Yan Hao; Yong-Jiang Li; Jun-Yong Wu; Da-Xiong Xiang; Shilin Luo
Journal:  Biomater Res       Date:  2022-09-30

10.  Inhibition of norovirus replication by morpholino oligomers targeting the 5'-end of the genome.

Authors:  Karin Bok; Victoria J Cavanaugh; David O Matson; Lorenzo González-Molleda; Kyeong-Ok Chang; Carmelann Zintz; Alvin W Smith; Patrick Iversen; Kim Y Green; Ann E Campbell
Journal:  Virology       Date:  2008-09-09       Impact factor: 3.616
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.